Genetic Technologies Limited (GENE)
NASDAQ: GENE · Real-Time Price · USD
0.765
0.00 (0.00%)
Nov 14, 2024, 4:00 PM EST - Market open
Genetic Technologies Ratios and Metrics
Market cap in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Nov '24 Nov 14, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 |
| Market Capitalization | 4 | 7 | 19 | 19 | 57 | 26 | |
| Market Cap Growth | -65.55% | -65.55% | 0.62% | -66.78% | 121.53% | 109.84% | |
| Enterprise Value | 4 | 4 | 16 | 10 | 45 | 24 | |
| Last Close Price | 1.50 | 1.50 | 4.15 | 5.80 | 21.25 | 11.40 | |
| PS Ratio | 1.03 | 1.03 | 2.79 | 3.01 | 57.42 | 44.84 | |
| PB Ratio | 5.42 | 5.42 | 2.58 | 1.69 | 3.56 | 2.68 | |
| P/TBV Ratio | - | - | 3.83 | 2.45 | 3.56 | 2.68 | |
| EV/Sales Ratio | 0.57 | 0.68 | 2.36 | 1.55 | 45.38 | 41.36 | |
| Debt / Equity Ratio | 0.48 | 0.48 | 0.05 | 0.04 | 0.01 | 0.03 | |
| Asset Turnover | 0.92 | 0.92 | 0.58 | 0.42 | 0.07 | 0.09 | |
| Inventory Turnover | 14.13 | 14.13 | 11.98 | 12.69 | 2.03 | 1.65 | |
| Quick Ratio | 0.75 | 0.75 | 2.96 | 3.72 | 15.64 | 10.74 | |
| Current Ratio | 0.88 | 0.88 | 3.17 | 3.86 | 15.82 | 10.87 | |
| Return on Equity (ROE) | -184.98% | -184.98% | -85.17% | -37.57% | -39.85% | -79.86% | |
| Return on Assets (ROA) | -62.93% | -62.93% | -36.52% | -21.54% | -24.03% | -39.28% | |
| Return on Capital (ROIC) | -91.95% | -91.95% | -45.24% | -24.29% | -25.62% | -45.69% | |
| Earnings Yield | -212.16% | -121.19% | -40.73% | -25.74% | -9.23% | -16.76% | |
| FCF Yield | -167.35% | -97.94% | -33.76% | -20.66% | -9.19% | -15.31% | |
| Buyback Yield / Dilution | -30.42% | -30.42% | -9.95% | -7.91% | -105.63% | -57.66% | |
| Total Shareholder Return | -30.42% | -30.42% | -9.95% | -7.91% | -105.63% | -57.66% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.